Rock Springs Capital Management’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Rock Springs Capital Management’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-377,700	Closed	-$7.25M	–	168
2020 Q4	$7.25M	Sell	377,700 -111,732	-23%	-$1.72M	0.15%	127
2020 Q3	$6.57M	Buy	489,432 +52,201	+12%	+$1.48M	0.17%	120
2020 Q2	$18.5M	Buy	437,231 +7,231	+2%	+$234K	0.51%	66
2020 Q1	$11.9M	Hold	430,000	–	–	0.49%	67
2019 Q4	$14M	Hold	430,000	–	–	0.44%	76
2019 Q3	$11.2M	Hold	430,000	–	–	0.45%	71
2019 Q2	$15.8M	Sell	430,000 -15,000	-3%	-$359K	0.57%	64
2019 Q1	$9.84M	Hold	445,000	–	–	0.38%	82
2018 Q4	$6.27M	Buy	445,000 +9,500	+2%	+$148K	0.3%	86
2018 Q3	$8.45M	Buy	435,500 +37,750	+9%	+$770K	0.31%	93
2018 Q2	$8.78M	Buy	397,750 +14,250	+4%	+$332K	0.34%	94
2018 Q1	$8.12M	Sell	383,500 -26,500	-6%	-$625K	0.35%	91
2017 Q4	$10.3M	Buy	+410,000	New	+$9.69M	0.47%	73

Other funds holding ODT

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Rock Springs Capital Management's ODT Position: Q1 2021 in Review

Rock Springs Capital Management sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2021, closing a stake of 377,700 shares — an estimated $7.25M sold.

Rock Springs Capital Management first reported a position in ODT in Q4 2017 and held it in 13 quarters. The position peaked at $18.5M in Q2 2020. 83 funds tracked by Wall St. Rank hold ODT as of Q1 2021.

Rock Springs Capital Management reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Rock Springs Capital Management sold 377,700 Odonate Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $7.25M.
Rock Springs Capital Management first reported a position in Odonate Therapeutics, Inc. Common Stock in Q4 2017 and held it in 13 quarters.
Rock Springs Capital Management's Odonate Therapeutics, Inc. Common Stock position peaked at $18.5M in Q2 2020.
83 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Rock Springs Capital Management's 13F filing for Q1 2021, filed 17 May 2021.